Physician

Jenna Alys Brunn, MD

According to 2025 Medicare claims, Jenna Brunn, MD (NPI: 1306406434) practices neurology in the Canton-Massillon, OH market, with the plurality of this provider's patient population coming from Stark, OH. This provider's primary affiliated billing organization is THE OAK CLINIC (NPI: 1447353594; TIN: 341930683) and primary practice location at 44685-7965. Brunn is affiliated with the POM ACO (ACO ID: A1297), participating under the MSSP model.

Brunn's data goes back to 2015 and runs through 2024. Part D data shows 439 prescription claims across 85 beneficiaries totaling $742,130 in drug costs, led by Kesimpta Pen (Ofatumumab). Open Payments data shows 28 records totaling $586. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,411 to $742,130. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

No connected Part B records

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	15	30	$1,411
2020	29	82	$16,896
2021	32	96	$17,344
2022	30	110	$17,297
2023	50	152	$193,684
2024	85	439	$742,130

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

No connected Part B code-level records for 2024.

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Kesimpta Pen	Ofatumumab	37	1,072	$354,624
Glatopa	Glatiramer Acetate	19	810	$92,194
Dalfampridine Er	Dalfampridine	59	2,010	$11,490
Dimethyl Fumarate	Dimethyl Fumarate	17	510	$8,908
Baclofen	Baclofen	41	2,347	$4,192

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	28	$586	TG Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jenna Alys Brunn, MD?

Tedicare shows public-source Medicare data for Jenna Alys Brunn, MD (NPI 1306406434), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jenna Alys Brunn, MD have ACO affiliation data?

Jenna Alys Brunn, MD is shown with ACO affiliation data for POM ACO (MSSP, ACO ID A1297).

What billing organization is linked to Jenna Alys Brunn, MD?

Jenna Alys Brunn, MD is linked to THE OAK CLINIC (billing NPI 1447353594) in the available physician profile data.

Does Jenna Alys Brunn, MD have Open Payments data?

Jenna Alys Brunn, MD has 28 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.